期刊文献+

临床药师参与1例新型隐球菌多部位感染伴AIDS患者抗真菌治疗的药学监护 被引量:2

Clinical Pharmacists Participating Pharmaceutical Care of Anti-fungal Medication of 1 AIDS Patient with Cryptococcus Neoformans
下载PDF
导出
摘要 目的:探究临床药师在新型隐球菌多部位感染合并AIDS患者抗真菌治疗的药学服务。方法:临床药师参与1例新型隐球菌多部位感染合并AIDS患者的药物治疗过程,从协助医师制定抗真菌药物治疗方案、药学监护、不良反应处理等方面提供药学服务。结果:临床药师参与药物治疗过程,调整抗感染方案,做好药学监护,患者病情逐步好转。结论:临床药师为医生合理安全用药提供建议,为患者提供药学服务,达到较好的治疗效果。 Objective:To study the pharmaceutical care methods of antifungal medication by clinical pharmacists in patients with Cryptococcal multi-site infection with AIDS.Methods:The clinical pharmacist participated in the drug treatment process of a case of Cryptococcus neoformans multi-site infection complicated with AIDS,and provided pharmaceutical care from the aspects of assisting doctors to formulate antifungal treatment plan,pharmaceutical care,adverse reaction management,etc..Results:After the clinical pharmacist participated in the process of drug medication,the patient’s condition was improved.Conclusion:Clinical pharmacists provided advice for doctors to use drugs reasonably and safely,provided pharmaceutical care for patients,and achieved better therapeutic effects.
作者 王林文 陈文颖 劳海燕 WANG Lin-wen;CHEN Wen-ying;LAO Hai-yan(Department of Pharmacy,Lianjiang People's Hospital,Lianjiang Guangdong 524400,China;Department of Pharmacy,The People's Hospital of Guangdong,Guangzhou 510080,China)
出处 《抗感染药学》 2020年第5期713-715,共3页 Anti-infection Pharmacy
关键词 新型隐球菌脑膜炎 肺隐球菌病 隐球菌血症 抗真菌药 药学监护 new type cryptococcal meningitis pulmonary cryptococcosis cryptococcemia antifungal drugs pharmaceutical care
  • 相关文献

参考文献6

二级参考文献37

  • 1石尧忠.隐球菌性脑膜炎的治疗[J].新药与临床,1996,15(5):306-308. 被引量:12
  • 2Segal BH, Herbreeht R, Stevens DA, et al. Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria. Clin Infect Dis, 2008, 47 : 674-683.
  • 3Saag MS, Graybill R J, Larsen RA, et al. Practice guidelines for the management of cryptococcal disease. Clin Infect Dis, 2000, 30:710-718.
  • 4Brouwer AE, Rajanuwong A, Chierakul W, et al. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomized trail. Lancet, 2004, 363 : 1764-1767.
  • 5Bicanic T, Wood R, Meintjes G, et al. High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients : a randomized trial. Clin Infect Dis, 2008, 47 : 123-130.
  • 6Van Der Horst CM, Saag MS, Cloud GA, et al. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical TriMs Group. N Engl J Med, 1997, 337:15-21.
  • 7Dromer Bernede-Bauduin F, C, Guillemot D, et al. Major role for amphotericin B-flucytosine combination in severe cryptococcosis. PLoS One, 2008, 3 :e2870-2879.
  • 8Bennett JE, Dismukes WE, Duma RV, et al. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal menin~tis. N Engl J Med, 1979, 301 : 126-131.
  • 9Dismukes WE, Cloud G, Gallis HA, et al. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. N Engl J Med, 1987, 317:334-341.
  • 10Pappas P, Perfect JR, Cloud GA, et al. Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis, 2001, 33:690-699.

共引文献556

同被引文献26

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部